WE ARE GUIDED BY CLEAR OBJECTIVES
goal
Enhancing global health helping people live longer and better lives.
Ambition
Increase our positive impact to strengthen our sustainable business model.
AND CORE VALUES
VALUES
Honesty
Transparency
Integrity
Independence
Safety & Quality
Ethics
Compliance
Human rights
Sustainability
Sustainability plan
strategic pillars
Commitment to patients and donors
Employee pool
Social impact
Environmental responsibility
WITH A STRATEGIC VISION AND THREE ESSENTIAL AREAS OF EMPHASIS
INNOVATION
ETHICAL COMMITMENT
FINANCIAL PERFORMANCE
OUR ACTIVITY HAS A POSITIVE IMPACT
value chain
Donors Production Distribution Patient
Input
Donors
920,000+
donors
390+
plasma centers
Innovation
Robust ecosystem
6
therapeutic areas
Employees
23,741
employees*
* Including Grifols and Biotest.
58%
women
92
nationalities
Governance
New leadership
36%
women board members
Resources
395 M
net R&D investment*
* Including Grifols and Biotest.
210 M
CAPEX*
* Including Grifols and Biotest.
Planet
32.8 M
environmental investment
3.6 Mm3
water consumption
928 M kWh
energy consumption
34.27%
renewable electricity
Value creation
Patients
800,000+
treated
27,370 M$
value creation (SROI**)
** Calculated with Social Return of Investment methodology, described in appendix.
6x
quality of life improvement***
***In relation to the cost of treatment. Improvement in quality of life calculated using SROI methodology.
8,3 M
product donations
7,7 M
patient programs and organizations
Employees
5,582,576
training hours
852
employees with disabilities*
* Including Grifols and Biotest.
99%
permanent contracts
69%
training hours delivered to women
Resources
6,592 M
revenue*
* Including Grifols and Biotest.
1,251 M
EBITDA*
* Including Grifols and Biotest.
695 M
total tax contributions
23.5 M
social contribution
Planet
83%
recovered ethanol
50%
recovered waste
33%
GHG Emissions reductions in relation to sales (Scope 1, 2 & 3)